Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Hertz completes $350 million senior secured notes offering
• Replimune (REPL) call put ratio 1.6 calls to 1 put